Rheumatology
535 East 70th Street
New York, NY 10021
New and Existing Patients
Already a patient?
Login or sign-upto Connect Patient Portal to make an appointment
Locations and Appointments
New Patients
About Sergio Schwartzman, M.D.
Board Certifications
- Internal Medicine
- Rheumatology
Expertise
- Antiphospholipid Syndrome
- Autoimmune Disorder
- Gout, Renal Disease
- Raynaud's Phenomenon
- Renal Disease In Autoimmune Disorders
- SLE (Systemic Lupus Erythematosus)
- Vasculitis
Education
- Fellowship: Hospital for Special Surgery/Weill Medical College
- Internship: Hospital for Special Surgery/Weill Medical College
- Medical School: Hospital for Special Surgery/Weill Medical College
- Residency: Hospital for Special Surgery/Weill Medical College
Languages
- English
Titles & Positions
- Associate Attending Physician
- Clinical Associate Professor of Medicine (Voluntary)
Hospital Affiliations
- NewYork-Presbyterian / Weill Cornell Medical Center
Education
- Fellowship: Hospital for Special Surgery/Weill Medical College
- Medical School: Hospital for Special Surgery/Weill Medical College
- Internship: Hospital for Special Surgery/Weill Medical College
- Residency: Hospital for Special Surgery/Weill Medical College
Titles & Positions
- Associate Attending Physician
- Clinical Associate Professor of Medicine (Voluntary)
Board Certifications
- internal medicine
- rheumatology
Languages Spoken
- english
Research
Ixekizumab and Malignant Neoplasms: A Pooled Analysis of Data From 25 Randomized Clinical Trials.
July 09, 2025Long-Term Safety of Ixekizumab Treatment in Patients with Psoriasis, Psoriatic Arthritis, or Axial Spondyloarthritis: a Post Hoc Analysis of Cerebro-Cardiovascular Events.
January 22, 2025Treatment-emergent Candida infections in patients with psoriasis, psoriatic arthritis, and axial spondyloarthritis treated with ixekizumab: an integrated safety analysis of 25 clinical studies.
September 12, 2024